ArticleJournal of nanobiotechnology2022

Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy.

Meixiao Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.